INVO Fertility, Inc. Common Stock (IVF)

• Market cap: $1.7M
• 1 day: 1.69%
• 5 days: -2.00%
• 1 month: -40.23%
• 3 months: -65.09%
• 6 months: -86.85%
• Year to date: -92.17%
• 1 year: -91.89%
• 5 years: -99.89%
• 10 years: -99.89%
• Sector: Healthcare
• Industry: Medical Devices

About: INVO Fertility Inc is a healthcare services fertility company dedicated to expanding assisted reproductive technology (ART) care to patients in need. It is offering the intravaginal culture (IVC) procedure enabled by INVOcell medical device (INVOcell). The INVOcell is a proprietary and revolutionary medical device, and the first to allow fertilization and early embryo development to take place in vivo within the woman's body. The company's segments include: The Clinics Services operating segment consisting of financial information for WFI and the Atlanta Clinic; The INVOcell Device operating segment consisting of financial information relating to the manufacture and sales of the INVOcell; and The Therapeutics segment consisting of financial information relating to acquired subsidiary, NTI.

Employees: 32

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

38% more capital invested

Capital invested by funds: $165K [Q4 2024] → $228K (+$62.8K) [Q1 2025]

12.47% more ownership

Funds ownership: 4.56% [Q4 2024] → 17.03% (+12.47%) [Q1 2025]

33% less funds holding

Funds holding: 9 [Q4 2024] → 6 (-3) [Q1 2025]

75% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 4

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 5